Global Allergy Immunotherapy Market: Industry Analysis and Forecast (2019-2026) – By Treatment Type, Allergy Type, Distribution Channels and Region

Global Allergy Immunotherapy Market was valued US$ XX Bn in 2018 and is expected to reach US$ 4.15 Bn by 2026, at a CAGR of around XX % during a forecast period. Global Allergy Immunotherapy Market To know about the Research Methodology :- Request Free Sample Report Allergy immunotherapy is a medical treatment targeted for treating different types of allergies. It is assumed that there is an increase in the prevalence of allergy cases universal and found that pharmacotherapy alone is not sufficient to control this disease. Thus allergy immunotherapeutic treatment helps to increase immunological tolerance and changes the development of disease owing to which needed for immunotherapy is increasing universally.The report study has analyzed revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers and market disrupters in the report and same is reflected in our analysis. The high prevalence and incidence rate of allergy across the globe, an increase in awareness about the treatment of allergy and high clinical research and development budget by governments are excepted to the driver of the global allergy immunotherapy market. The growing unmet need for novel targeted drugs, which are treated to disease conditions has growth opportunities for the market. However, the restricted healthcare expenditure in the underserved marketplaces of situations will restraint in the growth of allergy immunotherapy markets during the forecast period. Based on the treatment type, the subcutaneous immunotherapy (SCIT) segment is dominated by XX% during the forecast period, owing to its effectiveness to treat various allergies like asthma. SCIT segment identified as the leading allergy immunotherapy type that is preferred and adopted by most of the physicians. Additionally, compared with conventional treatment the cost-effectiveness of SCIT is high and novel particles under trials will assist the complete progression of allergy immunotherapy. The hospital pharmacy segment expected to dominate the XX% market share during the forecast period, owing to the growing patient pool in hospitals global for allergy treatment. Hospital pharmacies similarly allow clinics to provide quality medicines to a patient by purchasing straight from drug manufacturers thus avoiding the problem of counterfeit medicines. The high prevalence of chronic diseases is a dynamic factor in the hospital pharmacy segment. Regionally, Asia-Pacific is expected to account for the largest share of the allergy immunotherapy market during the forecast period. Because of the rising investments and exchange by the government for research and developments, growing the number of people pain from allergies, and industrialization and infrastructural development has improved air pollution in China and India. According to specialists, the basic issues responsible for the unexpected growth in allergic rhinitis is a product of changing the environment, development in hygiene and reduced infections, and increasing cases of genetic complications in allergy immunotherapy market. The report covers the recent development in the allergy immunotherapy market in August 2018, personalized medicine corporation announced its organization with multiple providers of allergen immunotherapy products for allergy testing to treat patients with allergy and asthma. Allergy treatment possibilities being offered at the hospital include sublingual immunotherapy and systematic allergy reports. The objective of the report is to present comprehensive analysis of global allergy immunotherapy market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers the all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding global allergy immunotherapy market dynamics, structure by analyzing the market segments, and project the global Allergy Immunotherapy market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the global allergy immunotherapy market make the report investor’s guide.

Scope of the Global Allergy Immunotherapy Market: Inquire before buying

Global Allergy Immunotherapy Market, By Treatment Type

• Subcutaneous Immunotherapy (SCIT) • Sublingual Immunotherapy (SLIT)

Global Allergy Immunotherapy Market, By Allergy Type

• Allergic Rhinitis • Allergic Asthma • Food Allergy • Venom Allergy • Others

Global Allergy Immunotherapy Market, By Distribution Channels

• Hospital Pharmacy • Retail Pharmacy • Online Pharmacy

Global Allergy Immunotherapy Market, By Region

• North America • Europe • Asia Pacific • Middle East & Africa • South America

Key players operating in the Global Allergy Immunotherapy Market

• Aimmune Therapeutics • ALK-Abello A/S • Stallergenes Greer • Allergy Therapeutics • Biomay AG • Merck KGaA • DBV Technologies • Circassia • WOLW Pharma • Holister Stier • HAL Allergy Group • Anergis.
Global Allergy Immunotherapy Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Allergy Immunotherapy Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Allergy Immunotherapy Market Analysis and Forecast 6.1. Global Allergy Immunotherapy Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Allergy Immunotherapy Market Analysis and Forecast, by Treatment Type 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Allergy Immunotherapy Market Value Share Analysis, by Treatment Type 7.4. Global Allergy Immunotherapy Market Size (US$ Bn) Forecast, by Treatment Type 7.5. Global Allergy Immunotherapy Market Analysis, by Treatment Type 7.6. Global Allergy Immunotherapy Market Attractiveness Analysis, by Treatment Type 8. Global Allergy Immunotherapy Market Analysis and Forecast, by Allergy Type 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Allergy Immunotherapy Market Value Share Analysis, by Allergy Type 8.4. Global Allergy Immunotherapy Market Size (US$ Bn) Forecast, by Allergy Type 8.5. Global Allergy Immunotherapy Market Analysis, by Allergy Type 8.6. Global Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type 9. Global Allergy Immunotherapy Market Analysis and Forecast, by Distribution Channels 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Allergy Immunotherapy Market Value Share Analysis, by Distribution Channels 9.4. Global Allergy Immunotherapy Market Size (US$ Bn) Forecast, by Distribution Channels 9.5. Global Allergy Immunotherapy Market Analysis, by Distribution Channels 9.6. Global Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channels 10. Global Allergy Immunotherapy Market Analysis, by Region 10.1. Global Allergy Immunotherapy Market Value Share Analysis, by Region 10.2. Global Allergy Immunotherapy Market Size (US$ Bn) Forecast, by Region 10.3. Global Allergy Immunotherapy Market Attractiveness Analysis, by Region 11. North America Allergy Immunotherapy Market Analysis 11.1. Key Findings 11.2. North America Allergy Immunotherapy Market Overview 11.3. North America Allergy Immunotherapy Market Value Share Analysis, by Treatment Type 11.4. North America Allergy Immunotherapy Market Forecast, by Treatment Type 11.4.1. Subcutaneous Immunotherapy (SCIT) 11.4.2. Sublingual Immunotherapy (SLIT) 11.5. North America Allergy Immunotherapy Market Value Share Analysis, by Allergy Type 11.6. North America Allergy Immunotherapy Market Forecast, by Allergy Type 11.6.1. Allergic Rhinitis 11.6.2. Allergic Asthma 11.6.3. Food Allergy 11.6.4. Venom Allergy 11.6.5. Others 11.7. North America Allergy Immunotherapy Market Value Share Analysis, by Distribution Channels 11.8. North America Allergy Immunotherapy Market Forecast, by Distribution Channels 11.8.1. Hospital Pharmacy 11.8.2. Retail Pharmacy 11.8.3. Online Pharmacy 11.9. North America Allergy Immunotherapy Market Value Share Analysis, by Country 11.10. North America Allergy Immunotherapy Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Allergy Immunotherapy Market Analysis, by Country 11.12. U.S. Allergy Immunotherapy Market Forecast, by Treatment Type 11.12.1. Subcutaneous Immunotherapy (SCIT) 11.12.2. Sublingual Immunotherapy (SLIT) 11.13. U.S. Allergy Immunotherapy Market Forecast, by Allergy Type 11.13.1. Allergic Rhinitis 11.13.2. Allergic Asthma 11.13.3. Food Allergy 11.13.4. Venom Allergy 11.13.5. Others 11.14. U.S. Allergy Immunotherapy Market Forecast, by Distribution Channels 11.14.1. Hospital Pharmacy 11.14.2. Retail Pharmacy 11.14.3. Online Pharmacy 11.15. Canada Allergy Immunotherapy Market Forecast, by Treatment Type 11.15.1. Subcutaneous Immunotherapy (SCIT) 11.15.2. Sublingual Immunotherapy (SLIT) 11.16. Canada Allergy Immunotherapy Market Forecast, by Allergy Type 11.16.1. Allergic Rhinitis 11.16.2. Allergic Asthma 11.16.3. Food Allergy 11.16.4. Venom Allergy 11.16.5. Others 11.17. Canada Allergy Immunotherapy Market Forecast, by Distribution Channels 11.17.1. Hospital Pharmacy 11.17.2. Retail Pharmacy 11.17.3. Online Pharmacy 11.18. North America Allergy Immunotherapy Market Attractiveness Analysis 11.18.1. By Treatment Type 11.18.2. By Allergy Type 11.18.3. By Distribution Channels 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Allergy Immunotherapy Market Analysis 12.1. Key Findings 12.2. Europe Allergy Immunotherapy Market Overview 12.3. Europe Allergy Immunotherapy Market Value Share Analysis, by Treatment Type 12.4. Europe Allergy Immunotherapy Market Forecast, by Treatment Type 12.4.1. Subcutaneous Immunotherapy (SCIT) 12.4.2. Sublingual Immunotherapy (SLIT) 12.5. Europe Allergy Immunotherapy Market Value Share Analysis, by Allergy Type 12.6. Europe Allergy Immunotherapy Market Forecast, by Allergy Type 12.6.1. Allergic Rhinitis 12.6.2. Allergic Asthma 12.6.3. Food Allergy 12.6.4. Venom Allergy 12.6.5. Others 12.7. Europe Allergy Immunotherapy Market Value Share Analysis, by Distribution Channels 12.8. Europe Allergy Immunotherapy Market Forecast, by Distribution Channels 12.8.1. Hospital Pharmacy 12.8.2. Retail Pharmacy 12.8.3. Online Pharmacy 12.9. Europe Allergy Immunotherapy Market Value Share Analysis, by Country 12.10. Europe Allergy Immunotherapy Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Allergy Immunotherapy Market Analysis, by Country 12.12. Europe Allergy Immunotherapy Market Forecast, by Treatment Type 12.12.1. Subcutaneous Immunotherapy (SCIT) 12.12.2. Sublingual Immunotherapy (SLIT) 12.13. Germany Allergy Immunotherapy Market Forecast, by Allergy Type 12.13.1. Allergic Rhinitis 12.13.2. Allergic Asthma 12.13.3. Food Allergy 12.13.4. Venom Allergy 12.13.5. Others 12.14. Germany Allergy Immunotherapy Market Forecast, by Distribution Channels 12.14.1. Hospital Pharmacy 12.14.2. Retail Pharmacy 12.14.3. Online Pharmacy 12.15. U.K. Allergy Immunotherapy Market Forecast, by Treatment Type 12.15.1. Subcutaneous Immunotherapy (SCIT) 12.15.2. Sublingual Immunotherapy (SLIT) 12.16. U.K. Allergy Immunotherapy Market Forecast, by Allergy Type 12.16.1. Allergic Rhinitis 12.16.2. Allergic Asthma 12.16.3. Food Allergy 12.16.4. Venom Allergy 12.16.5. Others 12.17. U.K. Allergy Immunotherapy Market Forecast, by Distribution Channels 12.17.1. Hospital Pharmacy 12.17.2. Retail Pharmacy 12.17.3. Online Pharmacy 12.18. France Allergy Immunotherapy Market Forecast, by Treatment Type 12.18.1. Subcutaneous Immunotherapy (SCIT) 12.18.2. Sublingual Immunotherapy (SLIT) 12.19. France Allergy Immunotherapy Market Forecast, by Allergy Type 12.19.1. Allergic Rhinitis 12.19.2. Allergic Asthma 12.19.3. Food Allergy 12.19.4. Venom Allergy 12.19.5. Others 12.20. France Allergy Immunotherapy Market Forecast, by Distribution Channels 12.20.1. Hospital Pharmacy 12.20.2. Retail Pharmacy 12.20.3. Online Pharmacy 12.21. Italy Allergy Immunotherapy Market Forecast, by Treatment Type 12.21.1. Subcutaneous Immunotherapy (SCIT) 12.21.2. Sublingual Immunotherapy (SLIT) 12.22. Italy Allergy Immunotherapy Market Forecast, by Allergy Type 12.22.1. Allergic Rhinitis 12.22.2. Allergic Asthma 12.22.3. Food Allergy 12.22.4. Venom Allergy 12.22.5. Others 12.23. Italy Allergy Immunotherapy Market Forecast, by Distribution Channels 12.23.1. Hospital Pharmacy 12.23.2. Retail Pharmacy 12.23.3. Online Pharmacy 12.24. Spain Allergy Immunotherapy Market Forecast, by Treatment Type 12.24.1. Subcutaneous Immunotherapy (SCIT) 12.24.2. Sublingual Immunotherapy (SLIT) 12.25. Spain Allergy Immunotherapy Market Forecast, by Allergy Type 12.25.1. Allergic Rhinitis 12.25.2. Allergic Asthma 12.25.3. Food Allergy 12.25.4. Venom Allergy 12.25.5. Others 12.26. Spain Allergy Immunotherapy Market Forecast, by Distribution Channels 12.26.1. Hospital Pharmacy 12.26.2. Retail Pharmacy 12.26.3. Online Pharmacy 12.27. Rest of Europe Allergy Immunotherapy Market Forecast, by Treatment Type 12.27.1. Subcutaneous Immunotherapy (SCIT) 12.27.2. Sublingual Immunotherapy (SLIT) 12.28. Rest of Europe Allergy Immunotherapy Market Forecast, by Allergy Type 12.28.1. Allergic Rhinitis 12.28.2. Allergic Asthma 12.28.3. Food Allergy 12.28.4. Venom Allergy 12.28.5. Others 12.29. Rest Of Europe Allergy Immunotherapy Market Forecast, by Distribution Channels 12.29.1. Hospital Pharmacy 12.29.2. Retail Pharmacy 12.29.3. Online Pharmacy 12.30. Europe Allergy Immunotherapy Market Attractiveness Analysis 12.30.1. By Treatment Type 12.30.2. By Allergy Type 12.30.3. By Distribution Channels 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Developments 13. Asia Pacific Allergy Immunotherapy Market Analysis 13.1. Key Findings 13.2. Asia Pacific Allergy Immunotherapy Market Overview 13.3. Asia Pacific Allergy Immunotherapy Market Value Share Analysis, by Treatment Type 13.4. Asia Pacific Allergy Immunotherapy Market Forecast, by Treatment Type 13.4.1. Subcutaneous Immunotherapy (SCIT) 13.4.2. Sublingual Immunotherapy (SLIT) 13.5. Asia Pacific Allergy Immunotherapy Market Value Share Analysis, By Allergy Type 13.6. Asia Pacific Allergy Immunotherapy Market Forecast, by Allergy Type 13.6.1. Allergic Rhinitis 13.6.2. Allergic Asthma 13.6.3. Food Allergy 13.6.4. Venom Allergy 13.6.5. Others 13.7. Asia Pacific Allergy Immunotherapy Market Value Share Analysis, by Distribution Channels 13.8. Asia Pacific Allergy Immunotherapy Market Forecast, by Distribution Channels 13.8.1. Hospital Pharmacy 13.8.2. Retail Pharmacy 13.8.3. Online Pharmacy 13.9. Asia Pacific Allergy Immunotherapy Market Value Share Analysis, by Country 13.10. Asia Pacific Allergy Immunotherapy Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Allergy Immunotherapy Market Analysis, by Country 13.12. China Allergy Immunotherapy Market Forecast, by Treatment Type 13.12.1. Subcutaneous Immunotherapy (SCIT) 13.12.2. Sublingual Immunotherapy (SLIT) 13.13. China Allergy Immunotherapy Market Forecast, by Allergy Type 13.13.1. Allergic Rhinitis 13.13.2. Allergic Asthma 13.13.3. Food Allergy 13.13.4. Venom Allergy 13.13.5. Others 13.14. China Allergy Immunotherapy Market Forecast, by Distribution Channels 13.14.1. Hospital Pharmacy 13.14.2. Retail Pharmacy 13.14.3. Online Pharmacy 13.15. India Allergy Immunotherapy Market Forecast, by Treatment Type 13.15.1. Subcutaneous Immunotherapy (SCIT) 13.15.2. Sublingual Immunotherapy (SLIT) 13.16. India Allergy Immunotherapy Market Forecast, by Allergy Type 13.16.1. Allergic Rhinitis 13.16.2. Allergic Asthma 13.16.3. Food Allergy 13.16.4. Venom Allergy 13.16.5. Others 13.17. India Allergy Immunotherapy Market Forecast, by Distribution Channels 13.17.1. Hospital Pharmacy 13.17.2. Retail Pharmacy 13.17.3. Online Pharmacy 13.18. Japan Allergy Immunotherapy Market Forecast, by Treatment Type 13.18.1. Subcutaneous Immunotherapy (SCIT) 13.18.2. Sublingual Immunotherapy (SLIT) 13.19. Japan Allergy Immunotherapy Market Forecast, by Allergy Type 13.19.1. Allergic Rhinitis 13.19.2. Allergic Asthma 13.19.3. Food Allergy 13.19.4. Venom Allergy 13.19.5. Others 13.20. Japan Allergy Immunotherapy Market Forecast, by Distribution Channels 13.20.1. Hospital Pharmacy 13.20.2. Retail Pharmacy 13.20.3. Online Pharmacy 13.21. ASEAN Allergy Immunotherapy Market Forecast, by Treatment Type 13.21.1. Subcutaneous Immunotherapy (SCIT) 13.21.2. Sublingual Immunotherapy (SLIT) 13.22. ASEAN Allergy Immunotherapy Market Forecast, by Allergy Type 13.22.1. Allergic Rhinitis 13.22.2. Allergic Asthma 13.22.3. Food Allergy 13.22.4. Venom Allergy 13.22.5. Others 13.23. ASEAN Allergy Immunotherapy Market Forecast, by Distribution Channels 13.23.1. Hospital Pharmacy 13.23.2. Retail Pharmacy 13.23.3. Online Pharmacy 13.24. Rest of Asia Pacific Allergy Immunotherapy Market Forecast, by Treatment Type 13.24.1. Subcutaneous Immunotherapy (SCIT) 13.24.2. Sublingual Immunotherapy (SLIT) 13.25. Rest of Asia Pacific Allergy Immunotherapy Market Forecast, by Allergy Type 13.25.1. Allergic Rhinitis 13.25.2. Allergic Asthma 13.25.3. Food Allergy 13.25.4. Venom Allergy 13.25.5. Others 13.26. Rest of Asia Pacific Allergy Immunotherapy Market Forecast, by Distribution Channels 13.26.1. Hospital Pharmacy 13.26.2. Retail Pharmacy 13.26.3. Online Pharmacy 13.27. Asia Pacific Allergy Immunotherapy Market Attractiveness Analysis 13.27.1. By Treatment Type 13.27.2. By Allergy Type 13.27.3. By Distribution Channels 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Developments 14. Middle East & Africa Allergy Immunotherapy Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Allergy Immunotherapy Market Overview 14.3. Middle East & Africa Allergy Immunotherapy Market Value Share Analysis, by Treatment Type 14.4. Middle East & Africa Allergy Immunotherapy Market Forecast, by Treatment Type 14.4.1. Subcutaneous Immunotherapy (SCIT) 14.4.2. Sublingual Immunotherapy (SLIT) 14.5. Middle East & Africa Allergy Immunotherapy Market Value Share Analysis, By Allergy Type 14.6. Middle East & Africa Allergy Immunotherapy Market Forecast, by Allergy Type 14.6.1. Allergic Rhinitis 14.6.2. Allergic Asthma 14.6.3. Food Allergy 14.6.4. Venom Allergy 14.6.5. Others 14.7. Middle East & Africa Allergy Immunotherapy Market Value Share Analysis, by Distribution Channels 14.8. Middle East & Africa Allergy Immunotherapy Market Forecast, by Distribution Channels 14.8.1. Hospital Pharmacy 14.8.2. Retail Pharmacy 14.8.3. Online Pharmacy 14.9. Middle East & Africa Allergy Immunotherapy Market Value Share Analysis, by Country 14.10. Middle East & Africa Allergy Immunotherapy Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Allergy Immunotherapy Market Analysis, by Country 14.12. GCC Allergy Immunotherapy Market Forecast, by Treatment Type 14.12.1. Subcutaneous Immunotherapy (SCIT) 14.12.2. Sublingual Immunotherapy (SLIT) 14.13. GCC Allergy Immunotherapy Market Forecast, by Allergy Type 14.13.1. Allergic Rhinitis 14.13.2. Allergic Asthma 14.13.3. Food Allergy 14.13.4. Venom Allergy 14.13.5. Others 14.14. GCC Allergy Immunotherapy Market Forecast, by Distribution Channels 14.14.1. Hospital Pharmacy 14.14.2. Retail Pharmacy 14.14.3. Online Pharmacy 14.15. South Africa Allergy Immunotherapy Market Forecast, by Treatment Type 14.15.1. Subcutaneous Immunotherapy (SCIT) 14.15.2. Sublingual Immunotherapy (SLIT) 14.16. South Africa Allergy Immunotherapy Market Forecast, by Allergy Type 14.16.1. Allergic Rhinitis 14.16.2. Allergic Asthma 14.16.3. Food Allergy 14.16.4. Venom Allergy 14.16.5. Others 14.17. South Africa Allergy Immunotherapy Market Forecast, by Distribution Channels 14.17.1. Hospital Pharmacy 14.17.2. Retail Pharmacy 14.17.3. Online Pharmacy 14.18. Rest of Middle East & Africa Allergy Immunotherapy Market Forecast, by Treatment Type 14.18.1. Subcutaneous Immunotherapy (SCIT) 14.18.2. Sublingual Immunotherapy (SLIT) 14.19. Rest of Middle East & Africa Allergy Immunotherapy Market Forecast, by Allergy Type 14.19.1. Allergic Rhinitis 14.19.2. Allergic Asthma 14.19.3. Food Allergy 14.19.4. Venom Allergy 14.19.5. Others 14.20. Rest of Middle East & Africa Allergy Immunotherapy Market Forecast, by Distribution Channels 14.20.1. Hospital Pharmacy 14.20.2. Retail Pharmacy 14.20.3. Online Pharmacy 14.21. Middle East & Africa Allergy Immunotherapy Market Attractiveness Analysis 14.21.1.1. By Treatment Type 14.21.1.2. By Allergy Type 14.21.1.3. By Distribution Channels 14.21.1.4. PEST Analysis 14.21.1.5. Key Trends 14.21.1.6. Key Developments 15. South America Allergy Immunotherapy Market Analysis 15.1. Key Findings 15.2. South America Allergy Immunotherapy Market Overview 15.3. South America Allergy Immunotherapy Market Value Share Analysis, by Treatment Type 15.4. South America Allergy Immunotherapy Market Forecast, by Treatment Type 15.4.1. Subcutaneous Immunotherapy (SCIT) 15.4.2. Sublingual Immunotherapy (SLIT) 15.5. South America Allergy Immunotherapy Market Value Share Analysis, By Allergy Type 15.6. South America Allergy Immunotherapy Market Forecast, by Allergy Type 15.6.1. Allergic Rhinitis 15.6.2. Allergic Asthma 15.6.3. Food Allergy 15.6.4. Venom Allergy 15.6.5. Others 15.7. South America Allergy Immunotherapy Market Value Share Analysis, by Distribution Channels 15.8. South America Allergy Immunotherapy Market Forecast, by Distribution Channels 15.8.1. Hospital Pharmacy 15.8.2. Retail Pharmacy 15.8.3. Online Pharmacy 15.9. South America Allergy Immunotherapy Market Value Share Analysis, by Country 15.10. South America Allergy Immunotherapy Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Allergy Immunotherapy Market Analysis, by Country 15.12. Brazil Allergy Immunotherapy Market Forecast, by Treatment Type 15.12.1. Subcutaneous Immunotherapy (SCIT) 15.12.2. Sublingual Immunotherapy (SLIT) 15.13. Brazil Allergy Immunotherapy Market Forecast, by Allergy Type 15.13.1. Allergic Rhinitis 15.13.2. Allergic Asthma 15.13.3. Food Allergy 15.13.4. Venom Allergy 15.13.5. Others 15.14. Brazil Allergy Immunotherapy Market Forecast, by Distribution Channels 15.14.1. Hospital Pharmacy 15.14.2. Retail Pharmacy 15.14.3. Online Pharmacy 15.15. Mexico Allergy Immunotherapy Market Forecast, by Treatment Type 15.15.1. Subcutaneous Immunotherapy (SCIT) 15.15.2. Sublingual Immunotherapy (SLIT) 15.16. Mexico Allergy Immunotherapy Market Forecast, by Allergy Type 15.16.1. Allergic Rhinitis 15.16.2. Allergic Asthma 15.16.3. Food Allergy 15.16.4. Venom Allergy 15.16.5. Others 15.17. Mexico Allergy Immunotherapy Market Forecast, by Distribution Channels 15.17.1. Hospital Pharmacy 15.17.2. Retail Pharmacy 15.17.3. Online Pharmacy 15.18. Rest of South America Allergy Immunotherapy Market Forecast, by Treatment Type 15.18.1. Subcutaneous Immunotherapy (SCIT) 15.18.2. Sublingual Immunotherapy (SLIT) 15.19. Rest of South America Allergy Immunotherapy Market Forecast, by Allergy Type 15.19.1. Allergic Rhinitis 15.19.2. Allergic Asthma 15.19.3. Food Allergy 15.19.4. Venom Allergy 15.19.5. Others 15.20. Rest of South America Allergy Immunotherapy Market Forecast, by Distribution Channels 15.20.1. Hospital Pharmacy 15.20.2. Retail Pharmacy 15.20.3. Online Pharmacy 15.21. South America Allergy Immunotherapy Market Attractiveness Analysis 15.21.1. By Treatment Type 15.21.2. By Allergy Type 15.21.3. By Distribution Channels 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Aimmune Therapeutics 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Development Footprint 16.3.2. ALK-Abello A/S 16.3.3. Stallergenes Greer 16.3.4. Allergy Therapeutics 16.3.5. Biomay AG 16.3.6. Merck KGaA 16.3.7. DBV Technologies 16.3.8. Circassia 16.3.9. WOLW Pharma 16.3.10. Holister Stier 16.3.11. HAL Allergy Group 16.3.12. Anergis. 17. Primary Key Insights

About This Report

Report ID 37109
Category Healthcare
Published Date Nov 2019
Updated Date Oct 2020
Contact Us